Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor maintenance update and does not affect study content or eligibility details.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page shows a minor site revision from v3.4.0 to v3.4.1 with no changes to the study content, eligibility criteria, or reported outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page adds a Locations section listing study sites in California, New Jersey, Pennsylvania, and Rio Grande do Sul, Brazil, and records revision v3.3.3. The previous location blocks are removed or reorganized.SummaryDifference0.5%

- Check112 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 on the page. This appears to be a minor versioning update that does not change study content or functionality.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.